A PYMNTS Company

E.U.: Highest court backs more than 50M euro fine for AstraZeneca

By  |  December 6, 2012

The European Court of Justice, the European Union’s highest court, backed a fine issued to AstraZeneca after the pharmaceutical company was found to have hampered competition by blocking rivals from its ulcer drug Losec and selling it for less money. The fine is a validation of the General Court’s, Europe’s second-highest court, 2010 decision to support the European Commission’s finding that AstraZeneca had breached competition law, but is also supportive of of the General Court’s decision to lower the fine originally administered by the Commission of €60 million to €52.5 million.

Full Content: Fox Business

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.